Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer
2023.2000 -3.40 (-0.17%)
NSE Jun 12, 2025 15:31 PM
Volume: 1.4M
 

logo
Lupin Ltd.
24 Apr 2024
2023.20
-0.17%
Axis Direct
Niche product approvals and a strong pipeline of new drugs could drive Revenue/PAT CAGR by 10%/19.5% over FY24E-FY26E. We maintain our BUY rating with a Target Price of Rs 1,770/share.
Lupin Ltd. has gained 25.35% in the last 1 Year
More from Lupin Ltd.
Recommended